Maximum Weekly Dose of Nurtec (Rimegepant)
For acute treatment of migraine, the maximum dose is 75 mg in a 24-hour period, with a safety limit of 18 doses per 30-day period, which translates to approximately 4-5 doses per week maximum. 1
Dosing Guidelines by Indication
Acute Treatment of Migraine
- Single dose: 75 mg orally as needed 1
- Maximum in 24 hours: 75 mg (one dose only) 1
- Monthly safety limit: The safety of using more than 18 doses in a 30-day period has not been established 1
- Weekly calculation: This 30-day limit translates to approximately 4-5 doses maximum per week on average 1
Preventive Treatment of Episodic Migraine
- Dosing schedule: 75 mg every other day 1
- Weekly total: This equals 3-4 doses per week (approximately 262.5 mg weekly) 1
Important Dosing Restrictions
Drug Interaction Considerations
When rimegepant is used with certain medications, additional dose spacing is required:
- With moderate CYP3A4 inhibitors: Avoid another dose within 48 hours 1
- With potent P-gp inhibitors: Avoid another dose within 48 hours 1
- With strong CYP3A4 inhibitors: Avoid concomitant administration entirely 1
- With strong or moderate CYP3A inducers: Avoid concomitant administration (may lead to loss of efficacy) 1
Clinical Context
The FDA labeling establishes clear safety boundaries that have not been studied beyond 18 doses per month for acute treatment 1. In long-term safety studies, rimegepant was administered up to once per calendar day for acute treatment (PRN dosing) or every other day plus PRN dosing for breakthrough attacks, demonstrating a favorable safety profile 2. However, the formal safety limit remains 18 doses per 30-day period for acute treatment use 1.
For preventive treatment, the consistent dosing is 75 mg every other day, which provides a predictable weekly exposure of 3-4 doses 1. This preventive regimen has demonstrated efficacy with reduction in monthly migraine days and durable benefits extending to 64 weeks 3, 4.